Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
latest_posts
- 1
Ethiopian earthquakes and volcanic eruptions: earth scientist explains the link - 2This Huge Ocean Beast Shifts Sharks’ Evolutionary Timeline
- 3Are IDF reservists properly armed during post-war operations?
- 4Amid growing bipartisan scrutiny of Pete Hegseth, Trump says he 'wouldn't have wanted … a second strike' on alleged Venezuelan drug boat survivors
- 5How to identify animal tracks, burrows and other signs of wildlife in your neighborhood
- US healthcare spending soars to over $5 trillion in 2024
- China's Normal Ponders: A Visual Excursion
- Taylor Swift just released the 'Elizabeth Taylor' music video — but she's not the star of it
- Manual for Tracking down the Immaculate Magnificence of Focal Asia
- Gilead's new HIV prevention shot added to CVS's drug coverage lists, CEO says
- 'Harmonious' meeting between Merz, Lula despite Belém controversy
- Top 15 Online Entertainment Stages for Individual Marking
- German-Polish man charged with calling for attacks on top politicians
- Rocket Lab launches mystery satellite for 'confidential commercial customer' (video)
